Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 4/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5167569 | 0.82 | IDO1 (0.46) | TAAR1IDO1MAOBMAPTCA12 | |
| SCHEMBL23927282 | 0.80 | IDO1 (0.59) | TAAR1IDO1MAOBMAPTCA12 | |
| SCHEMBL5696929 | 0.79 | TAAR1 (0.48) | TAAR1IDO1MAOBKMT2A | |
| SCHEMBL5169242 | 0.78 | IDO1 (0.42) | TAAR1IDO1MAPTBCHEACHE | |
| SCHEMBL7531508 | 0.78 | IDO1 (0.49) | TAAR1IDO1MAOBMAPTCA12 | |
| SCHEMBL2025850 | 0.75 | TAAR1 (0.76) | TAAR1IDO1MAOB | |
| SCHEMBL10435945 | 0.75 | CYP2C19 (0.52) | TAAR1IDO1 | |
| Hydrochloric Acid SCHEMBL5154716 | 0.73 | TAAR1 (0.73) | TAAR1IDO1MAOB | |
| SCHEMBL5200498 | 0.73 | TAAR1 (0.73) | TAAR1IDO1MAOB | |
| SCHEMBL13319587 | 0.73 | MAPT (0.53) | TAAR1IDO1MAOBMAPTBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187846-B1 | 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS | BAYER SCHERING PHARMA AG (DE) | 2007-04-18 | — | — | EP | disclosed |